Immunohistochemical expression of thymidylate synthase as predictor of response to capecitabine in patients with advanced colorectal adenocarcinoma

APMIS

Volumn 113, Issue 9, 2005, Pages 600-602

  Lindebjerg, J ^a   Nielsen, J Nederby ^a   Hoeffding, L Damkier ^a   Jakobsen, A ^a   Lindebjerg, Jan ^a  

^a LILLEBAELT HOSPITAL   (Denmark)

Author keywords

Capecitabine; Colorectal adenocarcinoma; Immunohistochemistry; Thymidylate synthase

Indexed keywords

CAPECITABINE; FLUOROPYRIMIDINE; FLUOROURACIL; THYMIDYLATE SYNTHASE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; HUMANS; IMMUNOHISTOCHEMISTRY; THYMIDYLATE SYNTHASE; TREATMENT OUTCOME;

EID: 27644549567     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2005.apm_201.x     Document Type: Article

References (6)

1. Ishitsuka H. Capecitabine: preclinical pharmacology studies. Invest New Drugs 2000;18:343-54.
2. Yamachika T, Nakanishi H, Inada K, Tsukamoto T, Kato T, Fukushima M, et al. A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance. Cancer 1998;82:70-7.
3. Johnston PG, Benson AB, Catalano P, Rao MS, O'Dwyer PJ, Allegra CJ. Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol 2003;21:815-9.
4. Edler D, Glimelius B, Hallström M, Jakobsen A, Johnston PG, Magnusson I, et al. Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. J Clin Oncol 2002;20:1721-8.
5. Lindebjerg J, Nielsen JN, Hoeffding LD, Bisgaard C, Brandslund I, Jakobsen A. Expression of thymidylate synthase in colorectal adenocarcinoma. Appl Immunohistochem Mol Morphol (in press).
6. Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer. Int J Colorectal Dis 2002;17:46-9.